Back
Roundhill GLP-1 & Weight Loss ETF Vs. Amplify Weight Loss Drug & Treatment ETF Industry Stock Comparison
Sell
42
OZEM
Roundhill GLP-1 & Weight Loss ETF
Last Price:
26.57
Seasonality Move:
--
Sell
12
THNR
Amplify Weight Loss Drug & Treatment ETF
Last Price:
24.00
Seasonality Move:
--
Sell
42
Roundhill GLP-1 & Weight Loss ETF (OZEM)
is a Sell
Is Roundhill GLP-1 & Weight Loss ETF a Buy, Sell or Hold?
- The current Roundhill GLP-1 & Weight Loss ETF [OZEM] share price is $26.58. The Score for OZEM is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- OZEM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
12
Amplify Weight Loss Drug & Treatment ETF (THNR)
is a Sell
Is Amplify Weight Loss Drug & Treatment ETF a Buy, Sell or Hold?
- The current Amplify Weight Loss Drug & Treatment ETF [THNR] share price is $23.94. The Score for THNR is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- THNR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
OZEM Stock Price Chart
What is Roundhill GLP-1 & Weight Loss ETF's stock price today?
-
The Roundhill GLP-1 & Weight Loss ETF share price today is $26.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OZEM is experiencing selling pressure, which indicates risk of future bearish movement.
THNR Stock Price Chart
What is Amplify Weight Loss Drug & Treatment ETF's stock price today?
-
The Amplify Weight Loss Drug & Treatment ETF share price today is $23.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THNR is experiencing slight selling pressure.
OZEM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 33.9 | Sell |
| Chaikin Money Flow: | -121357 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.17 - 28.53) | Sell |
| Bollinger Bands (100): | (26.93 - 28.51) | Sell |
THNR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 18.5 | Sell |
| Chaikin Money Flow: | -1098 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.84 - 26.38) | Sell |
| Bollinger Bands (100): | (25.6 - 27.34) | Sell |
OZEM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.11 | Sell |
| 20-day SMA: | 27.66 | Sell |
| 50-day SMA: | 27.96 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 27.12 | Sell |
| 20-day EMA: | 27.5 | Sell |
| 50-day EMA: | 27.73 | Sell |
| 200-day EMA: | 9.38 | Buy |
THNR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.69 | Sell |
| 20-day SMA: | 25.38 | Sell |
| 50-day SMA: | 26.3 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 24.65 | Sell |
| 20-day EMA: | 25.24 | Sell |
| 50-day EMA: | 25.92 | Sell |
| 200-day EMA: | 7.62 | Buy |
Roundhill GLP-1 & Weight Loss ETF Earnings Growth & OZEM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amplify Weight Loss Drug & Treatment ETF Earnings Growth & THNR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Roundhill GLP-1 & Weight Loss ETF Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amplify Weight Loss Drug & Treatment ETF Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||